• Profile
Close

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: No correlation with clinico-pathological characteristics and outcomes

Breast Cancer Research Aug 26, 2017

Curtit E, et al. – The hypothesis that the 94–(single nucleotide polymorphism (SNP)–based risk score was associated with clinico–pathological characteristics, breast cancer subtypes and outcomes in early breast cancer, was examined. This study did not observe any association between a risk score based on 94 SNPs and breast cancer characteristics, cancer subtypes, or patients’ outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay